Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jivan Biologics was a biotechnology company specializing in transcriptome analysis and the study of alternative splicing. The company developed the TransSplicer microarray platform, which allowed researchers to detect and quantify splice variants across the entire human genome. Their technology was primarily utilized in drug discovery and development to identify novel biomarkers and understand the functional diversity of the proteome. Jivan provided both custom microarray design and comprehensive genomic services to pharmaceutical and academic partners. Although the company is no longer active, it was a pioneer in the field of high-throughput alternative splicing analysis.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jivan Biologics.